Matthijs A. Velders

985 total citations
25 papers, 741 citations indexed

About

Matthijs A. Velders is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Matthijs A. Velders has authored 25 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Matthijs A. Velders's work include Acute Myocardial Infarction Research (12 papers), Coronary Interventions and Diagnostics (11 papers) and Cardiac Valve Diseases and Treatments (8 papers). Matthijs A. Velders is often cited by papers focused on Acute Myocardial Infarction Research (12 papers), Coronary Interventions and Diagnostics (11 papers) and Cardiac Valve Diseases and Treatments (8 papers). Matthijs A. Velders collaborates with scholars based in Netherlands, Sweden and United States. Matthijs A. Velders's co-authors include Adrianus J. van Boven, Martin J. Schalij, Sjoerd H. Hofma, Helèn Boden, Stefan James, Bas L. van der Hoeven, Suzanne C. Cannegieter, Michel Quéré, Jan Brouwer and J. Wouter Jukema and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and The American Journal of Cardiology.

In The Last Decade

Matthijs A. Velders

25 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthijs A. Velders Netherlands 14 576 385 183 79 61 25 741
J. Dens Belgium 9 517 0.9× 242 0.6× 328 1.8× 91 1.2× 50 0.8× 16 774
Cándido Martín‐Luengo Spain 15 366 0.6× 223 0.6× 76 0.4× 97 1.2× 61 1.0× 30 631
Tobias Koppara Germany 12 341 0.6× 526 1.4× 102 0.6× 225 2.8× 53 0.9× 38 710
Won Yu Kang South Korea 12 474 0.8× 348 0.9× 251 1.4× 109 1.4× 47 0.8× 36 685
Michał Plewka Poland 13 306 0.5× 153 0.4× 163 0.9× 56 0.7× 93 1.5× 58 512
Milan Dobrić Serbia 13 368 0.6× 230 0.6× 217 1.2× 89 1.1× 19 0.3× 57 577
Jorge Saucedo United States 12 471 0.8× 580 1.5× 239 1.3× 133 1.7× 15 0.2× 36 788
Juan B. Grau United States 16 816 1.4× 670 1.7× 112 0.6× 277 3.5× 9 0.1× 54 1.1k
Cemil İzgi United Kingdom 14 508 0.9× 177 0.5× 169 0.9× 156 2.0× 26 0.4× 45 721
Daniel Sürder Switzerland 15 659 1.1× 426 1.1× 144 0.8× 60 0.8× 77 1.3× 32 886

Countries citing papers authored by Matthijs A. Velders

Since Specialization
Citations

This map shows the geographic impact of Matthijs A. Velders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthijs A. Velders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthijs A. Velders more than expected).

Fields of papers citing papers by Matthijs A. Velders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthijs A. Velders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthijs A. Velders. The network helps show where Matthijs A. Velders may publish in the future.

Co-authorship network of co-authors of Matthijs A. Velders

This figure shows the co-authorship network connecting the top 25 collaborators of Matthijs A. Velders. A scholar is included among the top collaborators of Matthijs A. Velders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthijs A. Velders. Matthijs A. Velders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Velders, Matthijs A., Fredrik Calais, Tove Fall, et al.. (2019). Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction. Upsala Journal of Medical Sciences. 124(3). 187–192. 1 indexed citations
2.
Velders, Matthijs A., et al.. (2017). Call-to-balloon time dashboard in patients with ST-segment elevation myocardial infarction results in significant improvement in the logistic chain. EuroIntervention. 13(5). e564–e571. 8 indexed citations
3.
Haeck, Marlieke L.A., Georgette E. Hoogslag, Helèn Boden, et al.. (2016). Prognostic Implications of Elevated Pulmonary Artery Pressure After ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology. 118(3). 326–331. 11 indexed citations
4.
Velders, Matthijs A., Lars Wallentin, Richard C. Becker, et al.. (2015). Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial. American Heart Journal. 169(6). 879–889.e7. 42 indexed citations
5.
6.
Velders, Matthijs A., Adrianus J. van Boven, Pieter C. Smits, et al.. (2014). Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction. Netherlands Heart Journal. 22(4). 167–173. 5 indexed citations
7.
Hoogslag, Georgette E., Marlieke L.A. Haeck, Matthijs A. Velders, et al.. (2014). Determinants of Right Ventricular Remodeling Following ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology. 114(10). 1490–1496. 10 indexed citations
8.
Velders, Matthijs A., Helèn Boden, Bas L. van der Hoeven, et al.. (2013). Long-term outcome of second-generation everolimus-eluting stents and Endeavor zotarolimus-eluting stents in a prospective registry of ST-elevation myocardial infarction patients. EuroIntervention. 8(10). 1199–1206. 11 indexed citations
9.
10.
Boden, Helèn, Matthijs A. Velders, Bas L. van der Hoeven, Suzanne C. Cannegieter, & Martin J. Schalij. (2013). In-Hospital Major Bleeding and Its Clinical Relevance in Patients With ST Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. The American Journal of Cardiology. 112(10). 1533–1539. 17 indexed citations
11.
Ramshorst, Jan van, Georgette E. Hoogslag, Helèn Boden, et al.. (2013). Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up. Journal of Cardiovascular Translational Research. 6(5). 816–825. 89 indexed citations
12.
Velders, Matthijs A., Helèn Boden, Sjoerd H. Hofma, et al.. (2013). Outcome After ST Elevation Myocardial Infarction in Patients With Cancer Treated With Primary Percutaneous Coronary Intervention. The American Journal of Cardiology. 112(12). 1867–1872. 84 indexed citations
13.
14.
Velders, Matthijs A., et al.. (2013). Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents. PLoS ONE. 8(6). e64424–e64424. 13 indexed citations
15.
Hofma, Sjoerd H., Pieter C. Smits, Arnoud W.J. van ‘t Hof, Matthijs A. Velders, & Adrianus J. van Boven. (2013). TCT-238 Low Event Rates At Long-term Follow-up In The Randomized Myocardial Infarction XAMI Trial Comparing First And Second Generation Drug Eluting Stents. Journal of the American College of Cardiology. 62(18). B78–B78. 1 indexed citations
16.
Velders, Matthijs A., Helèn Boden, Bas L. van der Hoeven, et al.. (2012). OUTCOME OF SECOND-GENERATION EVEROLIMUS- AND ZOTAROLIMUS-ELUTING STENTS IN ST-ELEVATION MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. 59(13). E20–E20. 1 indexed citations
17.
Velders, Matthijs A., et al.. (2012). TCT-557 The Risk of In-Hospital Bleeding and Long-Term Mortality in Patients with ST Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 60(17). B161–B162. 3 indexed citations
18.
Velders, Matthijs A., Helèn Boden, Adrianus J. van Boven, et al.. (2012). Influence of Gender on Ischemic Times and Outcomes After ST-Elevation Myocardial Infarction. The American Journal of Cardiology. 111(3). 312–318. 47 indexed citations
19.
Park, Kyung Woo, Si‐Hyuck Kang, Matthijs A. Velders, et al.. (2012). Safety and efficacy of everolimus- versus sirolimus-eluting stents: A systematic review and meta-analysis of 11 randomized trials. American Heart Journal. 165(2). 241–250.e4. 58 indexed citations
20.
Hofma, Sjoerd H., Jan Brouwer, Matthijs A. Velders, et al.. (2012). Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus-Eluting Stents in Acute Myocardial Infarction. Journal of the American College of Cardiology. 60(5). 381–387. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Dens Breakdown of academic impact, for papers by Cándido Martín‐Luengo Breakdown of academic impact, for papers by Tobias Koppara Breakdown of academic impact, for papers by Won Yu Kang Breakdown of academic impact, for papers by Michał Plewka Breakdown of academic impact, for papers by Milan Dobrić Breakdown of academic impact, for papers by Jorge Saucedo Breakdown of academic impact, for papers by Juan B. Grau Breakdown of academic impact, for papers by Cemil İzgi Breakdown of academic impact, for papers by Daniel Sürder
Rankless by CCL
2026